Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists

Luteinizing hormone-releasing hormone agonists for prostate cancer patients: routine clinical practice of Russian cancer urologists

Background. Despite the recent amendments to the guidelines for the treatment of metastatic hormone-sensitive prostate cancer (PCa) implying standard use of luteinizing hormone-releasing hormone (LHRH) agonists in combination with chemotherapy or androgen inhibitors, androgen deprivation therapy (AD...

Full description

Bibliographic Details
Main Authors:	V. B. Matveev, B. Ya. Alekseev, B. Sh. Kamolov, A. S. Markova
Format:	Article
Language:	Russian
Published:	ABV-press 2021-07-01
Series:	Onkourologiâ
Subjects:	prostate cancer androgen deprivation therapy hormone therapy luteinizing hormone-releasing hormone agonists routine clinical practice non-interventional study
Online Access:	https://oncourology.abvpress.ru/oncur/article/view/1466

Similar Items

ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN
by: A. S. Markova, et al.
Published: (2014-07-01)

ANDROGEN DEPRIVATION THERAPY WITH LUTEINIZING HORMONE-RELEASING HORMONE ANTAGONISTS FOR PROSTATE CANCER: BEST DISEASE CONTROL WITH A LOWER RISK OF SIDE EFFECTS. RESULTS OF ANALYSIS OF 6 COMPARATIVE RANDOMIZED PHASE III TRIALS OF DEGARELIX AND LUTEINIZIN
by: A. S. Markova, et al.
Published: (2014-07-01)

Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients
by: Juan Morote, et al.
Published: (2017-10-01)

Hormone naïve prostate cancer: predicting and maximizing response intervals
by: Judd W Moul
Published: (2015-01-01)

Risk of Fracture During Androgen Deprivation Therapy Among Patients With Prostate Cancer: A Systematic Review and Meta-Analysis of Cohort Studies
by: Cheng Chih Wu, et al.
Published: (2021-08-01)

Kisspeptin receptor agonist (FTM080) increased plasma concentrations of luteinizing hormone in anestrous ewes
by: Brian K. Whitlock, et al.
Published: (2015-11-01)

Diferelin® as an effective chemical castration agent for patients with prostate cancer
by: K. M. Nyushko, et al.
Published: (2021-02-01)

Hormonal modulation of Leydig cell membrane luteinizing hormone receptors /
by: Hussein, Mohamed Osman
Published: (1986)

EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-07-01)

EFFICIENCY OF HORMONE THERAPY WITH LEIPRORELIN (LUCRIN DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-07-01)

INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER
by: B. Ya. Alekseyev, et al.
Published: (2014-07-01)

INTERMITTENT HORMONE THERAPY IN PATIENTS WITH PROSTATE CANCER
by: B. Ya. Alekseyev, et al.
Published: (2014-07-01)

Association of the genetic variants of luteinizing hormone, luteinizing hormone receptor and polycystic ovary syndrome
by: Liu Nana, et al.
Published: (2012-04-01)

HORMONAL THERAPY WITH LEUPRORELIN (LUCRIN-DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: I. G. Rusakov, et al.
Published: (2014-08-01)

HORMONAL THERAPY WITH LEUPRORELIN (LUCRIN-DEPOT®) IN PATIENTS WITH PROSTATE CANCER
by: I. G. Rusakov, et al.
Published: (2014-08-01)

Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women
by: Yen-Shen Lu, et al.
Published: (2021-09-01)

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines
by: Sipos E, et al.
Published: (2018-02-01)

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty
by: Stefanie Schubert, et al.
Published: (2021-06-01)

THE USE OF MODERN ANALOGUES OF LUTEINIZING HORMONE RELEASING HORMONE IN THE HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: E. Yu. Safronova, et al.
Published: (2017-06-01)

Effects of growth hormone administration on luteinizing hormone secretion in healthy older men and women
by: Ranganath Muniyappa, et al.
Published: (2017-12-01)

HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
by: K. M. Nyushko, et al.
Published: (2015-01-01)

Glycoprotein G-protein Coupled Receptors in Disease: Luteinizing Hormone Receptors and Follicle Stimulating Hormone Receptors
by: Duaa Althumairy, et al.
Published: (2020-09-01)

Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Eligard 45 mg in Russia
by: V. B. Matveev, et al.
Published: (2015-03-01)

Noninterventional studies of depot formulations of LHRH analogues for prostate cancer in routine clinical practice. The launch of an observational program to assess the use of Eligard 45 mg in Russia
by: V. B. Matveev, et al.
Published: (2015-03-01)

Luteinizing Hormone Levels Relate to the Unfavorable Pathology of Prostate Cancer
by: Se Young Choi, et al.
Published: (2020-04-01)

Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation
by: Dam Phuongan, et al.
Published: (2011-06-01)

Luteinizing Hormone Involvement in Aging Female Cognition: Not All Is Estrogen Loss
by: Sabina Bhatta, et al.
Published: (2018-09-01)

Luteinizing Hormone Releasing Hormone/Galactose Core/Lipopeptide
by: Pavla Simerska, et al.
Published: (2015-12-01)

Do basal luteinizing hormone and luteinizing hormone/follicle-stimulating hormone ratio have significance in prognosticating the outcome of In vitro fertilization cycles in polycystic ovary syndrome?
by: Neeta Singh, et al.
Published: (2021-01-01)

Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?
by: Dong Seong Lee, et al.
Published: (2013-12-01)

Attempts to induce puberty in beef heifers with luteinizing hormone-releasing hormone
by: Skaggs, Chris L.
Published: (2015)

The Diagnostic Utility of the Basal Luteinizing Hormone Level and Single 60-Minute Post GnRH Agonist Stimulation Test for Idiopathic Central Precocious Puberty in Girls
by: Ruixue Cao, et al.
Published: (2021-08-01)

Can fasting in the holy month of Ramadan affect on the levels of luteinizing hormone, follicle-stimulating hormone, and prolactin?
by: Sayed Alireza Mirsane, et al.
Published: (2017-09-01)

Recombinant luteinizing hormone supplementation in assisted reproductive technology: a review of literature
by: Maryam Eftekhar, et al.
Published: (2021-10-01)

Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies
by: K. M. Nyushko, et al.
Published: (2014-12-01)

Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies
by: K. M. Nyushko, et al.
Published: (2014-12-01)

Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: A cross-sectional study
by: Batool Hosein Rashidi, et al.
Published: (2019-03-01)

Luteinizing hormone releasing hormone analogues in the treatment of patients with prostate cancer
by: B. Ya. Alexeev, et al.
Published: (2018-11-01)

Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection
by: R. A. Gafanov, et al.
Published: (2019-01-01)

Seasonal melatonin and luteinizing hormone rhythms in muskoxen at 52° N
by: S. C. Tedesco, et al.
Published: (1992-10-01)